Danoprevir
id:
danoprevir-260-14500800
title:
Danoprevir
text:
Danoprevir (INN) is an orally available 15-membered macrocyclic peptidomimetic inhibitor of NS3/4A HCV protease. It contains acylsulfonamide, fluoroisoindole and tert-butyl carbamate moieties. Danoprevir is a clinical candidate based on its favorable potency profile against multiple HCV genotypes 1–6 and key mutants.
Danoprevir has been evaluated in an open-label, single arm clinical trial in combination with ritonavir for treating COVID-19 and favourably compared to lopinavir/ritonavir in a sec
brand slug:
wiki
category slug:
encyclopedia
description:
Medication
original url:
https://en.wikipedia.org/wiki/Danoprevir
date created:
date modified:
2023-10-20T04:54:36Z
main entity:
{"identifier":"Q27271364","url":"https://www.wikidata.org/entity/Q27271364"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/b/b4/Danoprevir.svg","width":512,"height":492}
fields total:
13
integrity:
15